HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rebamipide and mosapride enhance pilocarpine-induced salivation.

AbstractBACKGROUND:
During esophageal acid clearance, salivation plays an important role in defending the esophageal mucosa. Mosapride, an agent used in chronic, long-term therapy of gastro-esophageal reflux disease (GERD) was regarded as mediating its efficacy through prokinetic properties. Rebamipide is also widely used as an anti-gastritis and anti-ulcer agent in GERD patients with chronic gastritis. The aim of this study is to investigate the effects of rebamipide, mosapride, and risperidone on the salivation induced by pilocarpine.
MATERIALS AND METHODS:
The experiments were conducted on 4-week male SD rats (120-150g). The salivation was induced by intraperitoneally administrated pilocarpine and saliva was collected using preweighted small cotton balls inserted into the animal's mouth every 30 min for 180 min. Thirteen minutes before intraperitoneal administration of pilocarpine, rebamipide, mosapride, and risperidone were administered intraduodenally. Control rats were conducted by intraperitoneal administration of saline and intraduodenal administration of 0.5% methylcellulose solution.
RESULTS:
The saliva weight at 0-30 min was significantly (p<0.01) increased after administration of pilocarpine, compared to control rats. An additional administration of mosapride and rebamipide increased the saliva weight at 0-30 min. The total volume of saliva for 150 min after administration of pilocarpine was the highest after preadministration of rebamipide, followed by mosapride, and risperidone.
CONCLUSIONS:
Increase in salivation produced by i.p. pilocarpine was enhanced by preadministration of rebamipide and mosapride.
AuthorsYoshihisa Urita, Toshiyasu Watanabe, Tadashi Maeda, Yosuke Sasaki, Kazuo Hike, Hiroshi Muto, Masaki Sanaka, Nagato Shimada, Hitoshi Nakajima, Motonobu Sugimoto
JournalNorth American journal of medical sciences (N Am J Med Sci) Vol. 1 Issue 3 Pg. 121-4 (Aug 2009) ISSN: 2250-1541 [Print] India
PMID22666683 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: